Why Do Researchers Study GHK-CU for Healthy Aging
All contraindications are reviewed during your consultation
If all-inclusive pricing with no surprises is your top priority, Fridays delivers
Ready to embark on your weightloss journey
Enhanced Recovery and Tissue Repair Growth hormone directly influences collagen synthesis , tendon health, and soft tissue remodeling
Alexander Kokkinos Carel Le Roux To view or add a comment, sign in Tirzepatide: Redefining Outcomes in Diabetes & Obesity Care Clinical trials show tirzepatide, a dual GIP/GLP-1 receptor agonist, is delivering results beyond expectations: Up to 20.9% mean weight loss at 72 weeks (SURMOUNT-1, NEJM) 94% risk reduction in progression from prediabetes to type 2 diabetes over 3 years Superior HbA1c reduction and weight control vs leading GLP-1 therapies (SURPASS program) With manageable side effects and durable outcomes, tirzepatide is reshaping how we approach metabolic disease